news
-
[Testimonial] Secondary dose checks ensure safe and accurate delivery of adaptive radiotherapy
- June 3, 2025
ThinkQA Secondary Dose Check software provides quality assurance for every fraction of adaptive radiotherapy without impacting the clinical workflow
-
Introducing ThinkQA-Unified PSQA at ESTRO 2025
- April 29, 2025
We are re-thinking your Patient QA experience, as your PSQA tasks should accomplish more in less time with less effort. Come visit us at ESTRO 2025 (booth#470) and check out the powerful ThinkQA design innovation – Unified PSQA to streamline Patient QA experience.
-
SNMMI Annual Meeting 2025
- April 7, 2025
The SNMMI (Society of Nuclear Medicine and Molecular Imaging) Annual Meeting
June 21-25, 2025
New Orleans, LA USA
Booth #1138 -
A Collapsed Cone Convolution Dose Engine Suitable for Secondary Dose Check and Patient QA Tasks in Online Adaptive Workflows
- April 2, 2025
ThinkQA Secondary dose check solution relies on its modern dose calculation engine, an up-to-date point kernel Collapsed Cone Convolution (CCC) algorithm and implementation, tailored to comply with the specific requirements of online adaptive radiotherapy, including the Elekta Unity MR-linac specific considerations. The CCC dose engine is also a key component of a wider Patient-specific Quality Assurance solution, which becomes a mandatory element of modern online adaptive treatment workflows, using either MR- or CT-linacs.
-
ESTRO Annual Congress 2025
- April 2, 2025
European SocieTy for Radiotherapy & Oncology (ESTRO) Annual Meeting
May 2-6, 2025
Vienna, Austria
Booth #470 -
[Article] Commissioning of a Commercial Secondary Dose Check Software and Clinical Implementation for the Magnetic Resonance‑guided Linear Accelerator Adaptive Workflow
- April 2, 2025
José Alejandro Rojas‑López, Alexis Cabrera‑Santiago, Jorge Ramiro Corral‑Beltrán, Albin Ariel García-Andino
J Med Phys 2025;50:20-9. | DOI: 10.4103/jmp.jmp_150_24 -
[Poster] Puesta en Marcha de un Sistema de Cálculo Secundario de Dosis para un Acelerador Lineal con Resonancia Magnética*
- April 2, 2025
*Implementation of a Secondary Dose Calculation System for a Magnetic Resonance Linear Accelerator
Rojas-López JA, Cabrera-Santiago A, Corral-Beltán JR, García-Andino AA
Presented at ALFIM 2025 -
Turkish Society for Nuclear Medicine Annual Congress 2025
- April 1, 2025
Turkish Society for Nuclear Medicine Annual Congress
April 9-13, 2025
Antalya, Turkey -
DOSIsoft Announces New FDA 510(k) Clearance for PLANET® Onco Dose
- March 25, 2025
DOSIsoft, SA is proud to announce its latest product release, PLANET® Onco Dose version 3.2 received FDA 510(k) Clearance on March 14, 2025 from the US Food and Drug Administration, following its EU MDR CE Mark certification. The novel PLANET® platform is designed to incorporate a multi-radionuclide approach, implement multi-workflow solutions, and support multi-therapy applications for both SIRT (Selective Internal Radiation Therapy) and MRT (Molecular Radiation Therapy) while ensuring compliance with U.S. standards.
-
PLANET® Onco Dose Receives EU MDR CE Mark certification
- March 4, 2025
DOSIsoft is proud to announce that its latest product release, PLANET® Onco Dose version 3.2 – multi-radionuclide, personalized, voxel-based dosimetry platform for both SIRT and MRT – received Medical Device Regulation (MDR) CE Mark on February 17, 2025, under the new (EU) Regulation 2017/745.